San Francisco, CA, United States of America

Proteolix, Inc.

Calculating rank
USPTO Granted Patents = 5

% Expired Patents = 20.0



Forward Citations = 202

Loading Chart...
Loading Chart...

12 inventors (with patents filed for the assignee):

goldMedal Guy J Laidig (4 out of 31 patents)

silverMedal Mark Stephen Smyth (3 out of 41 patents)

bronzeMedal Craig M Crews (2 out of 34 patents)

4.  John H Musser (2 out of 113 patents)

5.  Ronald T Borchardt (2 out of 7 patents)

6.  Barry A Bunin (2 out of 6 patents)

7.  Han-Jie Zhou (1 out of 37 patents)

8.  Francesco Parlati (1 out of 21 patents)

9.  Mark K Bennett (1 out of 35 patents)

10.  Congcong M Sun (1 out of 6 patents)

11.  Kevin D Shenk (1 out of 27 patents)

12.  Monette Aujay (1 out of 5 patents)

13.  John Clifford Chabala (29 patents)

14.  Mark Nguyen Ho (1 patent)

15.  Fabiana N Fonseca (1 patent)


5 patents:

Company Overview
Proteolix, Inc. is a biopharmaceutical company focused on the development of novel therapies for the treatment of cancer. The company's lead product is a proteasome inhibitor with promising results in clinical trials for multiple myeloma and other hematologic malignancies. Proteolix is dedicated to advancing the field of oncology through innovative research and strategic partnerships.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 27 2026

5 Patents

#764 in San Francisco, CA

#12,079 in California

#51,669 in US

San Francisco, CA (US)
San Francisco, CA, United States of America
Forward Citations = 202

12 inventors:

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Proteolix, Inc.. Retrieved from https://idiyas.com/company/proteolix

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…